Onco Cell Therapy Summit Europe 2022, on 2-3 November in Amsterdam will gain multiple perspectives on how to attract investment from C-suite executives and investors whilst exploring European regulatory and reimbursement challenges for the cell therapy field.

    • Meet with 200+ of Europe’s leading innovators and investors, to drive partnership and collaboration and drive adoptive cell therapies to the market
    • Address durability, reduce exhaustion, and build in optimal approaches for targeting antigen heterogeneity to hit the tumour microenvironment
    • Explore genome-editing, iPSC-derived approaches and management strategies for chromosomal abnormalities and translocations for allogeneic cell therapy development
    • Establish robust, scalable and flexible vein-to-vein processes to enhance just in time delivery of cell therapies

    Event Venue: Amsterdam, Netherlands
    Event Date: 02-03 November, 2022
    Event website: https://hubs.ly/Q01j32JV0
    Event Organizer: Kisaco Research
    Contact number: +44 (0)20 3696 2920
    Email ID: marketing@kisacoresearch.com

    Organiser: Kisaco Research

    Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively.

    Kisaco Research produces, designs and hosts B2B industry conferences and exhibitions. Our platforms are neutral, so that our attendees get the right information from the most relevant people.